Related Experiment Video
Updated: Sep 20, 2025

Author Spotlight: A Selective Luciferase-Based Assay for Monitoring ATG4B 27 Activity in Cells
Published on: June 30, 2023
Differential regulation of STING expression and cisplatin sensitivity by autophagy in non-small cell lung cancer
Sevim Aydemir1, Zafer Yildirim1, Busra Bara1
1Faculty of Medicine, Department of Medical Biology, Ege University, Izmir, Türkiye.
Abstract:
The cGAS-STING pathway is a central signalling mechanism in inflammatory responses and can be activated by cisplatin. Increased autophagic activity has been linked to cisplatin resistance in non-small cell lung cancer (NSCLC); however, how autophagy-STING interactions influence the cisplatin response remains unclear. This study investigates how autophagy modulation affects STING expression and cisplatin sensitivity in NSCLC cells with different basal STING levels. Autophagy was inhibited using chloroquine and induced by serum starvation in Calu-1 and H2030 cells. In Calu-1 cells, cisplatin treatment increased STING expression, activated the cGAS-STING pathway, and induced interferon responses correlated with cisplatin concentration. Autophagy inhibition reduced STING expression and interferon activation while enhancing cisplatin sensitivity. Conversely, autophagy induction caused fluctuations in STING expression and decreased cisplatin sensitivity, with ISG15 expression being selectively increased under serum starvation. In contrast, H2030 cells exhibited low basal STING expression and showed minimal responses to cisplatin or autophagy modulation. These findings suggest that STING expression levels critically influence autophagy-mediated responses to DNA-damaging chemotherapy in NSCLC.
Insights
The cGAS-STING pathway
Area of Science:
- Cellular Biology
- Immunology
- Oncology
Background:
- The cyclic GMP-AMP synthase (cGAS)-stimulator of interferon genes (STING) pathway is crucial for inflammatory responses and is activated by cisplatin.
- Increased autophagy correlates with cisplatin resistance in non-small cell lung cancer (NSCLC), but the interplay between autophagy and STING in this context is unknown.
Purpose of the Study:
- To investigate how modulating autophagy impacts STING expression and cisplatin sensitivity in NSCLC cells with varying basal STING levels.
Main Methods:
- Autophagy was manipulated using chloroquine (inhibition) and serum starvation (induction) in Calu-1 and H2030 NSCLC cell lines.
- STING expression, cGAS-STING pathway activation, interferon responses, and cisplatin sensitivity were assessed.
Main Results:
- In Calu-1 cells (high basal STING), cisplatin increased STING, activated cGAS-STING, and induced interferon responses.
- Autophagy inhibition enhanced cisplatin sensitivity by reducing STING and interferon activation.
- Autophagy induction decreased cisplatin sensitivity, with serum starvation selectively increasing ISG15 expression.
- H2030 cells (low basal STING) showed minimal responses to cisplatin or autophagy modulation.
Conclusions:
- STING expression levels are critical determinants of autophagy-mediated responses to DNA-damaging chemotherapy in NSCLC.
- Targeting the autophagy-STING axis may offer therapeutic strategies for NSCLC.
Related Concept Videos
Autophagy
An autophagic pathway consists of a series of signaling events activated in response to diverse stress and physiological conditions such as food deprivation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Autophagic Cell Death
Autophagy and Apoptosis
Autophagy can activate apoptosis. In normal conditions, the autophagy activating protein Beclin-1 and...
The Intrinsic Apoptotic Pathway

